An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus
Condition(s):Diabetes; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2Last Updated:January 31, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Diabetes; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2Last Updated:January 31, 2017Completed
Condition(s):Type 2 DiabetesLast Updated:December 29, 2023Completed
Condition(s):Diabetes; HealthyLast Updated:February 24, 2017Completed
Condition(s):Diabetes; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2Last Updated:January 4, 2017Completed
Condition(s):Diabetes; Diabetes Mellitus, Type 2Last Updated:January 4, 2017Completed
Condition(s):Diabetes; Diabetes Mellitus, Type 2Last Updated:January 27, 2017Completed
Condition(s):Diabetes; Diabetes Mellitus, Type 2Last Updated:January 27, 2017Completed
Condition(s):Diabetes; Diabetes Mellitus, Type 1Last Updated:February 23, 2017Completed
Condition(s):Type 2 DiabetesLast Updated:June 30, 2021Completed
Condition(s):Type 1 DiabetesLast Updated:August 4, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.